FY2025 · period end Dec '25 · from the 10-K filed Feb 24, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $8.09B |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 10-Q | 0000073124-26-000035 | Mar 31, 2026 | Apr 30, 2026 | Apr 30, 2026 20:03 UTC | EDGAR |
| 8-K | 0000073124-26-000031 | Apr 21, 2026 | Apr 22, 2026 | Apr 22, 2026 20:08 UTC | EDGAR |
| 8-K | 0000073124-26-000028 | Apr 21, 2026 | Apr 21, 2026 | Apr 21, 2026 10:56 UTC | EDGAR |
| 8-K | 0000073124-26-000029 | Apr 21, 2026 | Apr 21, 2026 | Apr 21, 2026 16:17 UTC | EDGAR |
| 10-K | 0000073124-26-000016 | Dec 31, 2025 | Feb 24, 2026 | Feb 24, 2026 21:29 UTC | EDGAR |
| 8-K | 0000073124-26-000007 | Feb 10, 2026 | Feb 10, 2026 | Feb 10, 2026 17:10 UTC | EDGAR |
| 8-K | 0000073124-26-000005 | Jan 22, 2026 | Jan 22, 2026 | Jan 22, 2026 12:03 UTC | EDGAR |
| 8-K | 0001193125-25-288182 | Nov 19, 2025 | Nov 19, 2025 | Nov 19, 2025 21:33 UTC | EDGAR |
Direct links to SEC EDGAR. NTRS has additional filings available on the SEC site.
Figures a later SEC filing revised from what was first reported. Each diff compares the same XBRL tag across two filings — both linked, so you can check it yourself.
Net Income (Loss) Available to Common Stockholders, Diluted·Q1 2016
Minor restatementwas$231.9M
Revised up in a 10-Q.
Net Income (Loss) Available to Common Stockholders, Basic·Q1 2016
Minor restatementwas$235.9M
Revised up in a 10-Q.
Net Income (Loss) Attributable to Parent·Q1 2016
Minor restatementwas$241.8M
Revised up in a 10-Q. Any P/E built on the original was 1.5% too high.
Net Cash Provided by (Used in) Operating Activities·Q1 2016
Minor restatementwas-$299.1M
Revised up in a 10-Q.
Net Cash Provided by (Used in) Operating Activities·Q2 2016
Minor restatementwas-$513.1M
Revised up in a 10-Q.
Net Income (Loss) Available to Common Stockholders, Diluted·Q2 2016
Minor restatementwas$250.1M
Revised up in a 10-Q.
NTRS is not the only one.
See every restatement we've found across the market — or get an alert the next time NTRS revises a number.
Restatements are detected by comparing every vintage of a fact across all of NORTHERN TRUST CORP's filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows NTRS's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling NORTHERN TRUST CORP — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on NTRS yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on NTRS and publish the result to your public profile.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $6.77B |
| $6.76B |
| $6.46B |
| Gross Profit | — | — | — | — | — |
|---|
| Operating Income | — | — | — | — | — |
|---|
| Net Income | $1.74B | $2.03B | $1.11B | $1.34B | $1.55B |
|---|
| EPS (Diluted) | $8.74 | $9.77 | $5.08 | $6.14 | $7.14 |
|---|
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $177.13B | $155.51B | $150.78B | $155.04B | $183.89B |
| Total Liabilities | $164.17B | $142.72B | $138.89B | $143.78B | $171.87B |
| Stockholders' Equity | $12.96B | $12.79B | $11.90B | $11.26B | $12.02B |
| Cash & Equivalents | $5.87B | $4.68B | $4.79B | $4.65B | $3.06B |
| Total Debt | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $5.53B | negative: -$0.49B | $2.63B | $2.39B | $1.36B |
| Capital Expenditures | $0.07B | $0.10B | $0.12B | $0.13B | $0.10B |
| Free Cash Flow | $5.46B | negative: -$0.59B | $2.51B | $2.26B | $1.26B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | — |
| Operating Margin | 0.2% | 0.2% | 0.2% | 0.1% | 0.1% |
| Net Margin | 0.3% | 0.4% | 0.3% | 0.3% | 0.4% |
| Return on Equity | 13.5% | 16.5% | 9.6% | 11.5% | 13.0% |
| Return on Assets | 1.0% | 1.3% | 0.7% | 0.8% | 0.9% |
| Debt / Equity | 0.04× | — | — | 0.35× | — |
